Table 5.

Univariate analyses of factors associated with Relapse-free Survival and Overall Survival in ER positive breast cancer patients (n= 58).

Variables	Relapse-free Survival			Overall survival
	HR	95% CI	p	HR	95% CI	p
CD4 (>16)	3.66	1.22 to 10.98	0.022	2.67	1.07 to 6.59	0.035
CD8 (>13)	0.06	0.008 to 0.47	0.0001	0.15	0.04 to 0.49	0.0002
γδ T (>9)	26.45	3.41 to 205.07	4.26E-06	28.11	3.62 to 218.08	2.04E-06
FoxP3 (>12)	10.33	2.28 to 46.76	0.0002	5.33	1.93 to 14.73	0.0004
HER2 (Pos)	0.42	0.05 to 3.38	0.471	0.64	0.08 to 5.03	0.688
Stage (III vs I + II)	10.55	3.19 to 34.81	5.24E-5	5.76	2.27 to 14.62	0.0002
Nodal (Pos)	21.82	2.801 to 170.01	2.07E-05	10.27	2.96 to 35.61	7.58E-06
Size (>2.1)	3.29	1.01 to 10.74	0.037	4.26	1.54 to 11.81	0.002

Note: Results obtained using the Cox proportional hazard regression model.

Abbreviations: HR, hazard ratio; HER2, human epidermal growth factor receptor 2; FoxP3, forkhead box protein P3.